1. Types or Techniques Probability Sampling

PHARMAQUEST (c) This method maintains the procedure of the finding evaluate the reliability of the sample. Disadvantages (a) This technique of sampling cannot be used for a large sample.It is applicable only for small sample. (b) This technique is time consuming, costly, and requires more competition.(c) Its planning and administration is more complicated.

  Sampling

FORMULATION AND EVALUATION OF VARIOUS …

PHARMAQUEST FORMULATION AND EVALUATION OF VARIOUS COSMETIC AND DENTAL PRODUCT 1) DEFINITION:- The term cosmetics have been derived from the term “COSMETIKOS” which means the skill to decorate.

  Evaluation, Various, Formulation, Formulation and evaluation of various

RESEARCH METHODOLOGY Methods and tools use in …

RESEARCH METHODOLOGY 2011 4 3. Quasi-experimental design Quasi-experimental designs were developed to provide alternate means for examining causality in situations which were not conducive to experimental control. The designs have been developed to …

  Research, Design, Methodology, Research methodology

PHARMACEUTICAL PACKAGING, COMPONENT AND …

Pharmaceutical Packaging: Pharmaceutical packaging means the combination of components necessary to contain, preserve, protect & deliver a safe, efficacious drug product, such that at any time point before expiration date of the drug product, a safe & efficacious dosage form is available. Types of Packaging Systems:

  Packaging

Importance, Objectives & Factors Affecting Dissolution ...

The processes involved in dissolution of solid dosage forms: ... Micronization of hydrophobic powders can lead to aggregation and floatation when powder is dispersed into dissolution medium. So, mere increase in S.A. of drug does not ... resulting in imparting hydrophilic character to granules & thus increase in effective surface area & rate of ...

  Form, Powder, Solid, Dissolution, Dosage, Granules, Solid dosage forms

ORDER OF REACTION - PharmaQuesT

When the reaction rate is independent of concentration of the reacting substance, it depends on the zero power of the reactant and therefore is zero order reaction. In this type of reaction, the limiting factor is something other than concentration, for example, solubility or absorption of light in certain photochemical reactions.

  Reactions, The creation

PRODUCTION PLANNING AND PRODUCTION CONTROL

The main objective of scheduling is to arrange the work of the production in ... 2. Network analysis/ technique(CPM & PERT) 3. WORK BREAKDOWN STRUCTURE 4. MOTION STUDY (METHOD STUDY) 5. ... an American engineer and social scientist. Frequently used in project management, a Gantt chart provides a graphical illustration of a schedule that helps ...

  Project, Scheduling, Production, Pter

INTRODUCTION & APPLICATION OF SOLUBILITY & …

3. Solubility of solids in liquids 1.Solubility of gases in liquids Pharmaceutical solution of gases includes hydrochloric acid, ammonia water, and effervescent preparation containing carbon dioxide (Aerosol) that are dissolved and maintained in solution under positive pressure. The solubility of such system depends primarily on the pressure ...

  Liquid, Sage, Solubility, Solid, Solubility of gases, Of gases

FACTORS AFFECTING DRUG ABSORPTION - PharmaQuesT

(1) Membrane physiology A. Nature of cell membrane B. Transport processes (2) Gastero-Intestinal motility A. Gastric emptying rate B. Intestinal motility C. Drug stability in GIT D. pH of GIT E. Surface area of GIT F. Intestinal transit G. Blood flow to GIT. H. Effect of food

  Physiology, Absorption, Gastric

Regulatory Requirements Related to Stability Testing

Kinetic Mean Temperature (Virtual temperature) 21°C 26°C 31°C 31°C . Mean Annual Relative Humidity 45% 60% 40% 70% REQUIREMENT OF TEMPERATURE DEPENDED ON TYPE OF TESTING TYPE OF STUDY TEMPERATURE RELATIVE HUMIDITY TIME DURATION Long term 25°C ± 2°C /60% RH ± 5% RH 12 months ...

  Name, Stability, Temperatures, Kinetics, Mean kinetic temperature

ICH guideline Q3D (R1) on elemental impurities

follows the principles described in ICH Q3C: Residual Solvents. The available information was reviewed to establish the oral, parenteral and inhalation PDEs. For practical purposes, the PDEs to be applied to the drug product that are presented in Appendix 2 Table A.2.1 have been rounded to 1 or 2 significant figures.

  Ich q3c

IMPURITIES GUIDELINE FOR RESIDUAL S Q3C(R8) - ICH

Q3C(R8) Current Step 4 version dated 22 April 2021 This Guideline has been developed by the appropriate ICH Expert Working Group and has been subject to consultation by the regulatory parties, in accordance with the ICH Process. At Step 4 of the Process the final draft is recommended for adoption to the regulatory bodies of ICH

  Guidelines, Impurities, Residual, Impurities guideline for residual

令和2年6月26日 （ 公 印 省 略 - Pmda

れた公知のデータに基づいて評価が行われている。このプロセスは、ich q3c（残留溶媒）で述 べられた原則に準拠している。経口製剤、注射剤及び吸入剤におけるpde値を設定するために、 既存の情報を精査した。

  Ich q3c

Q11 Step 5 Development and manufacture of drug substances

designed to reduce impurities. In addition, ICH Q11 provides further clarification on the principles and concepts described in ICH guidelines on Pharmaceutical Development (Q8), Quality Risk Management (Q9) and Pharmaceutical Quality System (Q10) as they pertain to the development and manufacture of drug substance.

ICH HARMONISED TRIPARTITE GUIDELINE

3.2.S.2.6 (ICH M4Q). It addresses aspects of development and manufacture that pertain to drug substance, including the presence of steps designed to reduce impurities. In addition, ICH Q11 provides further clarification on the principles and concepts described in ICH Guidelines on Pharmaceutical Development (Q8), Quality Risk Management (Q9)

厚生労働省医薬局審査管理課長 - Pmda

薬品の残留溶媒ガイドライン」（平成10年3月30日医薬審第307号）（以下「ICH－Q3Cガ イドライン」という。）も参照すること。 1.3 ガイドラインの適用範囲

  Ich q3c